The Non-Small Cell Lung Cancer (NSCLC) Patient Decision Aid is a resource designed to facilitate treatment discussions between clinicians and patients. It was specifically designed for people living with advanced, unresectable NSCLC who have a confirmed epidermal growth factor receptor (EGFR) mutation.
The decision aid is not intended to provide medical advice and should not be relied upon as a substitute for a clinician’s medical judgment. Instead, it provides information about NSCLC, possible NSCLC treatment options, and questions to help patients reflect on their treatment preferences and goals.
Thank you for choosing this program. Information you provide may be shared by Johnson & Johnson Innovative Medicine with affiliates and third parties involved for the fulfillment of requests. Please be advised that the information you provide in the below form will be used to assist you in the implementation of this tool and a Johnson & Johnson Innovative Medicine Value & Evidence Scientific Engagement Associate will be contacting you in the near future. Any information you provide will be governed by our Privacy Policy. By completing this form and clicking the below "Confirm" button, you have read and acknowledge these statements.
I would like to access the Non-Small Cell Lung Cancer (NSCLC) Patient Decision Aid and I understand the following statements.